In contrast to the positive regulation of gene copy number on IGF2BP3 expression, our current study provides evidence that promoter methylation serves as an inhibitory factor for IGF2BP3 expression in bladder cancer. Here, IGF2BP3 is linked to urinary bladder cancer.